Notable candidates in Phase II/III trials include arhalofenate (MBX102), AC201, the RDEA group (including lesinurad), tranilast, and ulodesine (BCX4208)
While naturally occurring and generally safe, NAC can interact powerfully with certain pharmaceutical medications, making medical supervision essential before starting supplementation
Some patients may require an even higher dose of 2 mg weekly for optimal effect, particularly for weight management indications, though this should be approached cautiously with careful monitoring for adverse effects
This paper elucidates hormesis within food science, examining how plant metabolites, fermentation products, and cooking byproducts modulate cellular defense networks via hormesis to impact health